TCT: Non-inferiority trial shows Synergy DES delivers Cardiovascular Business “The results really support the safety and efficacy of this novel bioabsorbable polymer Synergy everolimus-eluting stent for the treatment of patients with de novo coronary artery disease,” Meredith concluded, adding that more studies that examine ... Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and ... Boston Scientific SYNERGY™ Stent Demonstrates Comparable Safety and ... |
